{"id":13300,"date":"2023-01-25T10:10:45","date_gmt":"2023-01-25T18:10:45","guid":{"rendered":"https:\/\/mr66givry2.onrocket.site\/?p=13300"},"modified":"2026-01-01T10:12:13","modified_gmt":"2026-01-01T18:12:13","slug":"congress-ensures-dm-remains-eligible-prmrp-research-funding-sixth-year-row","status":"publish","type":"post","link":"https:\/\/myotonic.org\/de\/congress-ensures-dm-remains-eligible-prmrp-research-funding-sixth-year-row\/","title":{"rendered":"Congress Ensures DM Remains Eligible For PRMRP Research Funding For Sixth Year in A Row"},"content":{"rendered":"<div>\n<h2 class=\"date-of-publication\"><strong>DM Researchers Awarded Record $8.8 Million in New Awards In Fiscal Year 2022<\/strong><\/h2>\n<\/div>\n<div>\n<div class=\"clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item\">\n<p>On December 23rd, Congress passed the fiscal year 2023 Omnibus Appropriations bill which for the sixth year in a row ensures that myotonic dystrophy remains an eligible research condition under the Department of Defense Peer Reviewed Medical Research Program (PRMRP). To remain eligible for research funding, Congress approve all eligible diseases and conditions as part of the Senate Appropriations legislation.\u00a0To date, myotonic dystrophy researchers have been awarded $8.1 million under the program.<\/p>\n<p>Weeks after this announcement, PRMRP announced their fiscal year 2022 research awards and myotonic dystrophy researchers were awarded a record $8.8 million in new research grants.\u00a0Four DM researchers submitted grant applications and two researchers won awards.\u00a0This represents an excellent 50% success rate for DM!\u00a0Details on the researchers and research topics will be announced soon.<\/p>\n<p>Myotonic Dystrophy Foundation advocates from across the country have successfully educated Congress on the importance of PRMRP program eligibility for over the past decade.\u00a0We are continuing to strive to increase federal funding for myotonic dystrophy research across the government including at the National Institutes of Health.\u00a0Our success is helping to drive new scientific discoveries and drug development.\u00a0While there are still no Food and Drug Administration (FDA) approved treatments for myotonic dystrophy, several promising myotonic dystrophy treatments are entering clinical trials and research advocacy is vital to keep funding new science.<\/p>\n<h2>Become a PRMRP Consumer Reviewer<\/h2>\n<p>Individuals living with myotonic dystrophy, caregivers, advocates, and researchers focused on the myotonic dystrophy, play an important role in helping the PRMRP program better understand the effects of myotonic dystrophy, the life experience, and areas of clinical importance.\u00a0Over 2,000 consumers, including myotonic dystrophy advocates, have served as Peer and Programmatic reviewers since 1995.\u00a0Having a myotonic dystrophy consumer voice serving on the Peer and Programmatic review panels is critically important as we seek to increase federal funding for important new myotonic dystrophy research.<\/p>\n<p>To learn more about being a PRMRP consumer reviewer, please contact the Myotonic Dystrophy Foundation and visit the PRMRP consumer reviewer overview webpage at:\u00a0<a href=\"https:\/\/cdmrp.health.mil\/cwg\/default\" target=\"_blank\" rel=\"noopener\">https:\/\/cdmrp.health.mil\/cwg\/default<\/a><\/p>\n<div class=\"col-xs-12 col-sm-6 col-md-4 col-lg-2 pull-right\"><img decoding=\"async\" class=\"\" src=\"https:\/\/upload.wikimedia.org\/wikipedia\/en\/thumb\/9\/9d\/Rare_Disease_Day.svg\/360px-Rare_Disease_Day.svg.png\" width=\"199\" height=\"179\" \/>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DM Researchers Awarded Record $8.8 Million in New Awards In Fiscal Year 2022 On December 23rd, Congress passed the fiscal year 2023 Omnibus Appropriations bill which for the sixth year in a row ensures that myotonic dystrophy remains an eligible research condition under the Department of Defense Peer Reviewed Medical Research Program (PRMRP). To remain [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[161],"tags":[],"class_list":["post-13300","post","type-post","status-publish","format-standard","hentry","category-non-classe"],"_links":{"self":[{"href":"https:\/\/myotonic.org\/de\/wp-json\/wp\/v2\/posts\/13300","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myotonic.org\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myotonic.org\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myotonic.org\/de\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/myotonic.org\/de\/wp-json\/wp\/v2\/comments?post=13300"}],"version-history":[{"count":0,"href":"https:\/\/myotonic.org\/de\/wp-json\/wp\/v2\/posts\/13300\/revisions"}],"wp:attachment":[{"href":"https:\/\/myotonic.org\/de\/wp-json\/wp\/v2\/media?parent=13300"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myotonic.org\/de\/wp-json\/wp\/v2\/categories?post=13300"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myotonic.org\/de\/wp-json\/wp\/v2\/tags?post=13300"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}